Masimo SET® Pulse Oximetry: Superior Performance, Global Reach, Lasting Impact

Masimo (NASDAQ: MASI) Signal Extraction Technology® (SET®) pulse oximetry, known for its industry-leading accuracy and clinical validation, continues to set the standard in overcoming the limitations of conventional pulse oximetry. As of 2024, Masimo SET® is the primary pulse oximetry…

Read MoreMasimo SET® Pulse Oximetry: Superior Performance, Global Reach, Lasting Impact

Techstars and Northwestern Medicine Launch Healthcare Innovation Accelerator

Techstars, a leading pre-seed investor, is partnering with Northwestern Medicine to launch the Northwestern Medicine & Techstars Healthcare Accelerator, a new program focused on driving healthcare innovation. The accelerator will invest in promising early-stage healthcare startups, providing founders with the…

Read MoreTechstars and Northwestern Medicine Launch Healthcare Innovation Accelerator

GE HealthCare Unveils AI-Enhanced Cardiology Solutions for Real-Time Imaging at ESC 2024

GE HealthCare (Nasdaq: GEHC) has announced the CE marks for its Vscan Air™ SL wireless handheld ultrasound system, now integrated with Caption AI™ software, which uses artificial intelligence to enable rapid cardiac assessments at the point of care. Additionally, the…

Read MoreGE HealthCare Unveils AI-Enhanced Cardiology Solutions for Real-Time Imaging at ESC 2024

Creekside Family Practice Reports 90% Online Appointment Scheduling with eClinicalWorks EHR and healow

eClinicalWorks®, the leading provider of cloud-based EHR systems, has announced that Creekside Family Practice is effectively using eClinicalWorks EHR and healow® Open Access® for online appointment scheduling. The practice has reported that 90% of their monthly appointments are scheduled through…

Read MoreCreekside Family Practice Reports 90% Online Appointment Scheduling with eClinicalWorks EHR and healow

Guardant Health to Ring Nasdaq Bell on August 28 for Shield™ Colorectal Cancer Test Launch

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology firm, will ring the Nasdaq opening bell at MarketSite in Times Square, New York on Wednesday, August 28, 2024. “Today, we celebrate the launch of Shield, our FDA-approved blood-based test for…

Read MoreGuardant Health to Ring Nasdaq Bell on August 28 for Shield™ Colorectal Cancer Test Launch

Simulations Plus Restructures Business Units to Support Growth After Recent Acquisitions

Simulations Plus, Inc. (Nasdaq: SLP), a top provider of biosimulation, simulation-enabled performance, intelligence solutions, and medical communications for the biopharma industry, has announced an optimization of its business unit and leadership structure. This strategic move, effective August 30, 2024, is…

Read MoreSimulations Plus Restructures Business Units to Support Growth After Recent Acquisitions